PBMCs from glioblastoma patients exhibited increased expression of the regulatory genes <i>SOCS1</i>, <i>SOCS3</i>, and <i>PTEN,</i> while <i>CCND1</i> was downregulated. This evidence concerns the gene SOCS3 and glioblastoma.